TY - JOUR
T1 - The Relationship between Latent Tuberculosis Infection and Acute Myocardial Infarction
AU - Huaman, Moises A.
AU - Ticona, Eduardo
AU - Miranda, Gustavo
AU - Kryscio, Richard J.
AU - Mugruza, Raquel
AU - Aranda, Ernesto
AU - Rondan, Paola L.
AU - Henson, David
AU - Ticona, Cesar
AU - Sterling, Timothy R.
AU - Fichtenbaum, Carl J.
AU - Garvy, Beth A.
PY - 2018/3/5
Y1 - 2018/3/5
N2 - © 2017 The Author(s). Background. Tuberculosis has been associated with an increased risk of cardiovascular disease (CVD), including acute myocardial infarction (AMI). We investigated whether latent tuberculosis infection (LTBI) is associated with AMI. Methods. We conducted a case-control study in 2 large national public hospital networks in Lima, Peru, between July 2015 and March 2017. Case patients were patients with a frst time diagnosis of type 1 (spontaneous) AMI. Controls were patients without a history of AMI. We excluded patients with known human immunodefciency virus infection, tuberculosis disease, or prior LTBI treatment. We used the QuantiFERON-TB Gold In-Tube assay to identify LTBI. We used logistic regression modeling to estimate the odds ratio (OR) of LTBI in AMI case patients versus non-AMI controls. Results. We enrolled 105 AMI case patients and 110 non-AMI controls during the study period. Overall, the median age was 62 years (interquartile range, 56-70 years); 69% of patients were male; 64% had hypertension, 40% dyslipidemia, and 39% diabetes mellitus; 30% used tobacco; and 24% were obese. AMI case patients were more likely than controls to be male (80% vs 59%; P <.01) and tobacco users (41% vs 20%; P <.01). LTBI was more frequent in AMI case patients than in controls (64% vs 49% [P =.03]; OR, 1.86; 95% confdence interval [CI], 1.08-3.22). Afer adjustment for age, sex, hypertension, dyslipidemia, diabetes mellitus, tobacco use, obesity, and family history of coronary artery disease, LTBI remained independently associated with AMI (adjusted OR, 1.90; 95% CI, 1.05-3.45). Conclusions. LTBI was independently associated with AMI. Our results suggest a potentially important role of LTBI in CVD.
AB - © 2017 The Author(s). Background. Tuberculosis has been associated with an increased risk of cardiovascular disease (CVD), including acute myocardial infarction (AMI). We investigated whether latent tuberculosis infection (LTBI) is associated with AMI. Methods. We conducted a case-control study in 2 large national public hospital networks in Lima, Peru, between July 2015 and March 2017. Case patients were patients with a frst time diagnosis of type 1 (spontaneous) AMI. Controls were patients without a history of AMI. We excluded patients with known human immunodefciency virus infection, tuberculosis disease, or prior LTBI treatment. We used the QuantiFERON-TB Gold In-Tube assay to identify LTBI. We used logistic regression modeling to estimate the odds ratio (OR) of LTBI in AMI case patients versus non-AMI controls. Results. We enrolled 105 AMI case patients and 110 non-AMI controls during the study period. Overall, the median age was 62 years (interquartile range, 56-70 years); 69% of patients were male; 64% had hypertension, 40% dyslipidemia, and 39% diabetes mellitus; 30% used tobacco; and 24% were obese. AMI case patients were more likely than controls to be male (80% vs 59%; P <.01) and tobacco users (41% vs 20%; P <.01). LTBI was more frequent in AMI case patients than in controls (64% vs 49% [P =.03]; OR, 1.86; 95% confdence interval [CI], 1.08-3.22). Afer adjustment for age, sex, hypertension, dyslipidemia, diabetes mellitus, tobacco use, obesity, and family history of coronary artery disease, LTBI remained independently associated with AMI (adjusted OR, 1.90; 95% CI, 1.05-3.45). Conclusions. LTBI was independently associated with AMI. Our results suggest a potentially important role of LTBI in CVD.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85043448649&origin=inward
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85043448649&origin=inward
U2 - 10.1093/cid/cix910
DO - 10.1093/cid/cix910
M3 - Article
SN - 1058-4838
SP - 886
EP - 892
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
ER -